Health
J&J, AstraZeneca explore COVID-19 vaccine modification after blood clot reports – WSJ – Financial Post
Johnson & Johnson and AstraZeneca are conducting early research into whether modifications to their COVID-19 vaccines could eliminate…
Johnson & Johnson and AstraZeneca are conducting early research into whether modifications to their COVID-19 vaccines could eliminate or reduce the risk of rare blood clots linked to the shots, the Wall Street Journal reported, citing people close to the…
Continue Reading
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News20 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
Noosa News21 hours agoCountdown on for Noosa Eat & Drink Festival 2025
-
Noosa News18 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up